Nathan Post

Nathan Post has over a decade of experience advising and operating biotechnology companies. He is focused on guiding teams in articulating and refining value hypotheses and aligning resources to establish, scale, and transform operations.

Nathan began his career as a strategy analyst at Deloitte Consulting, where he focused on CNS market access strategy and pipeline lifecycle management. Following Deloitte, he entered the biotechnology venture ecosystem and has since supported company development in both direct leadership and advisory roles.

At Indigo Agriculture, a Flagship Pioneering company, Nathan led the zero-to-one development of an online crop marketplace that became the company’s primary business line and accelerated sales of its existing portfolio of microbiological crop-input products. He subsequently served as Chief of Staff, partnering with the board of directors to onboard a new CEO and with the executive team on product portfolio strategy, fundraising, and internal transformation.

Following Indigo, Nathan was Director of Finance, Strategy, and Operations at Matterhorn Biosciences, where he led all corporate operations, including establishing the company’s U.S. footprint and scaling business functions to support its growth. He also worked with company leadership to facilitate R&D and support strategic dialogue with the board.

Nathan received his Bachelors of Arts degree in Physics and Mathematics from Bowdoin College, where he served as captain of the rowing team.

TEAM

Pasha Sarraf, MD, PhD

Dr. Pasha Sarraf is a devoted physician-scientist with deep leadership experience across the business of life sciences, from pharma, to biotech, to Wall Street. His incisive decision-making ensures future value creation on every project he works on.

Read Bio

Andrew N Schwartzberg

Andrew Schwartzberg is one of the leading affordable housing developers in the United States and an active investor in companies focused on advancements in the life sciences.

Read Bio

Aaron Day-Williams, PhD

Dr. Aaron Day-Williams is a highly respected and collaborative computational geneticist and biologist who excels at transforming quantitative assessments of therapeutic hypotheses into actionable target identification, validation, and clinical development.

Read Bio

Dylan Dupuis, PhD

Dr. Dylan Dupuis is an experienced biotech analyst who skillfully applies qualitative and quantitative thinking to identify exceptional value in life sciences opportunities.

Read Bio

James Patterson, MD, PhD

Dr. James Patterson is an inventive physician-scientist and networked entrepreneur, skillfully founding, fundraising, and leading R&D efforts to create impactful therapeutics.

Read Bio

Nathan Edwards

Nathan Edwards has deep expertise in tactical and strategic financial management spanning project incubation to commercial launches, with a proactive and disciplined approach to portfolio optimization.

Read Bio

Nathan Post

Nathan Post is an operator experienced in building, scaling, and transforming biotechnology companies across a range of private investment stages.

Read Bio

Tongtong Zhao, PhD

Dr. Tongtong Zhao is a distinguished scientist and biotech innovator whose expertise spans analytical rigor, foundational research, and technology development central to company building.

Read Bio